Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrew Kotliar is active.

Publication


Featured researches published by Andrew Kotliar.


Bioorganic & Medicinal Chemistry Letters | 2003

Benzamide derivatives as blockers of Kv1.3 ion channel

Shouwu Miao; Jianming Bao; Maria L. Garcia; Joung L. Goulet; Xingfang J. Hong; Gregory J. Kaczorowski; Frank Kayser; Gloria C. Koo; Andrew Kotliar; William A. Schmalhofer; Kashmira Shah; Peter J. Sinclair; Robert S. Slaughter; Marty S. Springer; Mary Jo Staruch; Nancy N. Tsou; Frederick Wong; William H. Parsons; Kathleen M. Rupprecht

The voltage-gated potassium channel, Kv1.3, is present in human T-lymphocytes. Blockade of Kv1.3 results in T-cell depolarization, inhibition of T-cell activation, and attenuation of immune responses in vivo. A class of benzamide Kv1.3 channel inhibitors has been identified. The structure-activity relationship within this class of compounds in two functional assays, Rb_Kv and T-cell proliferation, is presented. In in vitro assays, trans isomers display moderate selectivity for binding to Kv1.3 over other Kv1.x channels present in human brain.


Archive | 1995

2,6-diaryl pyridazinones with immunosuppressant activity

Richard J. Bochis; Andrew Kotliar; William H. Parsons; Kathleen M. Rupprecht


Archive | 1999

Carbocyclic potassium channel inhibitors

Robert K. Baker; Jianming Bao; Jennifer Chee; Maria L. Garcia; Gregory J. Kaczorowski; Frank Kayser; Andrew Kotliar; Chou Juitsai Liu; Shouwu Miao; William H. Parsons; Kathleen M. Rupprecht; William A. Schmalhofer; Christopher F. Claiborne; David A. Claremon; Nigel Liverton; Wayne J. Thompson


Journal of Medicinal Chemistry | 1998

A Potent, Orally Bioavailable Benzazepinone Growth Hormone Secretagogue

Robert J. DeVita; Richard J. Bochis; Alison J. Frontier; Andrew Kotliar; Michael H. Fisher; William R. Schoen; Matthew J. Wyvratt; Kang Cheng; Wanda W.-S. Chan; Bridget Butler; Thomas M. Jacks; Gerard J. Hickey; Klaus D. Schleim; Kwan Leung; Zhesheng Chen; ‖ S.-H. Lee Chiu; William P. Feeney; and Paul K. Cunningham; Roy G. Smith


Archive | 1999

Heterocyclic potassium channel inhibitors

Jianming Bao; Andrew Kotliar; Frank Kayser; William H. Parsons; Kathleen M. Rupprecht; Christopher F. Claiborne; David A. Claremon; Nigel Liverton; Wayne J. Thompson


Archive | 1999

Benzamide potassium channel inhibitors

Robert K. Baker; Jianming Bao; Frank Kayser; Andrew Kotliar; William H. Parsons; Kathleen M. Rupprecht; Christopher F. Claiborne; David A. Claremon; Nigel Liverton; Wayne J. Thompson


Archive | 2001

5-CHLORO-3-(4-METHANESULFONYLPHENYL)-6'-METHYL- [2,3'] BIPYRIDINYL IN PURE CRYSTALLINE FORM AND PROCESS FOR SYNTHESIS

Louis S. Crocker; Ian W. Davies; Richard G. Osifchin; Andrew Kotliar


Bioorganic & Medicinal Chemistry Letters | 2005

Potent Kv1.3 inhibitors from correolide—modification of the C18 position

Jianming Bao; Shouwu Miao; Frank Kayser; Andrew Kotliar; Robert K. Baker; George A. Doss; John P. Felix; Randal M. Bugianesi; Robert S. Slaughter; Gregory J. Kaczorowski; Maria L. Garcia; Sookhee Ha; Laurie Castonguay; Gloria C. Koo; Kashmira Shah; Marty S. Springer; Mary Jo Staruch; William H. Parsons; Kathleen M. Rupprecht


Archive | 1998

Immunosuppressant tetracyclic triterpenes

Jianming Bao; Robert K. Baker; Frank Kayser; Andrew Kotliar; William H. Parsons; Kathleen M. Rupprecht; Peter J. Sinclair


Organic Letters | 2002

Novel fragmentation reaction of correolide.

Jianming Bao; Robert K. Baker; George A. Doss; Frank Kayser; Andrew Kotliar; Shouwu Miao; William H. Parsons; Kathleen M. Rupprecht

Collaboration


Dive into the Andrew Kotliar's collaboration.

Researchain Logo
Decentralizing Knowledge